Clinical Trial Update: A Study of Mavacamten in Adults With Obstructive Hypertrophic Cardiomyopathy in India (ROVER) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial in India evaluating mavacamten for symptomatic obstructive hypertrophic cardiomyopathy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy
• Obstructive Hypertrophic Cardiomyopathy

Drugs mentioned

• CAMZYOS (MAVACAMTEN)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Symptomatic Obstructive Hypertrophic Cardiomyopathy | Phase 4 | Status: RECRUITING